Institute for Infectious Diseases and Molecular Medicine, Division of Immunology, CLS, Faculty of Health Sciences, University of Cape Town, South Africa.
J Innate Immun. 2009;1(3):231-43. doi: 10.1159/000173703. Epub 2008 Nov 12.
The interactions between Mycobacterium tuberculosis and host phagocytes such as macrophages and dendritic cells are central to both immunity and pathogenesis. Many receptors have been implicated in recognition and binding of M. tuberculosis such as the mannose receptor, dendritic-cell-specific intercellular adhesion molecule-3 grabbing nonintegrin, dectin-1 and complement receptor 3 as well as Toll-like receptors, scavenger receptors and CD14. While in vitro studies have demonstrated clear roles for particular receptor(s), in vivo work in receptor-deficient animals often revealed only a minor, or no role, in infection with M. tuberculosis. The initial encounter of phagocytic cells with myco- bacteria appears to be complex and depends on various parameters. It seems likely that infection with M. tuberculosis does not occur via a single receptor-mediated pathway. Rather, multiple receptors play different roles in M. tuberculosis infection, and the overall effect depends on the expression and availability of a particular receptor on a particular cell type and its triggered downstream responses. Moreover, the role of membrane cholesterol for M. tuberculosis interactions with phagocytes adds to the complexity of mycobacterial recognition and response. This review summarizes current knowledge on non-opsonic receptors involved in binding of mycobacteria and discusses the contribution of individual receptors to the recognition process.
分枝杆菌与宿主吞噬细胞(如巨噬细胞和树突状细胞)之间的相互作用是免疫和发病机制的核心。许多受体已被牵涉到分枝杆菌的识别和结合中,如甘露糖受体、树突状细胞特异性细胞间黏附分子-3 抓取非整合素、dectin-1 和补体受体 3 以及 Toll 样受体、清道夫受体和 CD14。虽然体外研究已经证明了特定受体的明确作用,但在受体缺陷动物的体内研究中,分枝杆菌感染的作用往往只有很小,或者没有作用。吞噬细胞与分枝杆菌的初始接触似乎很复杂,取决于各种参数。似乎感染分枝杆菌不是通过单一的受体介导途径发生的。相反,多种受体在分枝杆菌感染中发挥不同的作用,整体效果取决于特定细胞类型上特定受体的表达和可用性及其触发的下游反应。此外,膜胆固醇在分枝杆菌与吞噬细胞相互作用中的作用增加了分枝杆菌识别和反应的复杂性。这篇综述总结了参与分枝杆菌结合的非调理受体的最新知识,并讨论了单个受体对识别过程的贡献。